Indications and uses
Helps prevent sunburn If used as directed with other sun protection measures ( see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun
Exuviance CoverBlend Skin Caring Foundation
- Manufacturer
- NeoStrata Company, Inc. | Kolmar Laboratories
- Effective date
- 2020-01-24
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 23:42:49
Label at a glance#
ProductExuviance CoverBlend Skin Caring Foundation SPF 20 Bisque
Active ingredientTITANIUM DIOXIDE
Label structure19 sections
Dosage and administration
Shake. Blend on evenly with fingertips 15 minutes before sun exposure. Use a water resistant sunscreen if swimming or sweating Reapply sunscreen at least every 2 hours Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a broad spectrum SPF of 15 or higher and other sun protection measures including: Limit ...
Storage and handling
Store at 15°C - 30°C (59°F - 86°F) Protect this product from excessive heat and direct sun
Contacts and useful links#
Label contents#
Full prescribing information#
SPL UNCLASSIFIED SECTION
Drug Facts
Active ingredients
Titanium Dioxide 7.8%
Purpose
Sunscreen
Uses
- Helps prevent sunburn
- If used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun
Warnings
For external use only
OTC - DO NOT USE SECTION
Do not use on damaged or broken skin
OTC - WHEN USING SECTION
When using this product keep out of eyes. Rinse with water to remove.
OTC - STOP USE SECTION
Stop use and ask a doctor if rash occurs
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. If product is swallowed, get medical help or contact a Poison Control Center right away.
Directions
- Shake. Blend on evenly with fingertips 15 minutes before sun exposure.
- Use a water resistant sunscreen if swimming or sweating
- Reapply sunscreen at least every 2 hours
- Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a broad spectrum SPF of 15 or higher and other sun protection measures including:
- Limit time in the sun, especially from 10 a.m. - 2 p.m.
- Wear long-sleeve shirts, pants, hats, and sunglasses
- Children under 6 months: Ask a doctor
Other information
- Store at 15°C - 30°C (59°F - 86°F)
- Protect this product from excessive heat and direct sun
Inactive ingredients
Aqua (Water), Cyclohexasiloxane, Cyclopentasiloxane, Isostearyl Neopentanoate, Talc, Gluconolactone, Isododecane, Butylene Glycol, Isohexadecane, Nylon-12, Polymethyl Methacrylate, Glycerin, Silica, Polyethylene, Sorbitan Sesquioleate, Disteardimonium Hectorite, PEG-30 Dipolyhydroxystearate, Sodium Chloride, Lactobionic Acid, Tocopheryl Linoleate/Oleate, Lecithin, Polyglyceryl-4 Isostearate, Hexyl Laurate, Stearic Acid, Aluminum Hydroxide, Propylene Carbonate, PEG/PPG-18/18 Dimethicone, Perfluorooctyl Triethoxysilane, Ammonium C6-16 Perfluoroalkylethyl Phosphate, Cetyl PEG/PPG-10/1 Dimethicone, Ammonium Hydroxide, Magnesium Stearate, Polymethylsilsesquioxane, Phenoxyethanol, Chlorphenesin. MAY CONTAIN: CI 77492 (Iron Oxide Yellow), CI 77491 (Iron Oxide Red), CI 77499 (Iron Oxide Black)
Questions or comments?
Call toll free 1-800-225-9411 (9am-5pm ET)
PRINCIPAL DISPLAY PANEL - 30 mL Bottle Carton - Bisque
DERMATOLOGIST DEVELOPED
Exuviance®
CB
CoverBlend
Skin Caring Foundation
with Sunscreen Broad Spectrum
SPF 20
Light to medium, all-day coverage
+
Powerful antiaging benefits
30 mL / 1.0 fl oz
PRINCIPAL DISPLAY PANEL - 30 mL Bottle Carton - Blush Beige
DERMATOLOGIST DEVELOPED
Exuviance®
CB
CoverBlend
Skin Caring Foundation
with Sunscreen Broad Spectrum
SPF 20
Light to medium, all-day coverage
+
Powerful antiaging benefits
30 mL / 1.0 fl oz
PRINCIPAL DISPLAY PANEL - 30 mL Bottle Carton - True Beige
DERMATOLOGIST DEVELOPED
Exuviance®
CB
CoverBlend
Skin Caring Foundation
with Sunscreen Broad Spectrum
SPF 20
Light to medium, all-day coverage
+
Powerful antiaging benefits
30 mL / 1.0 fl oz
PRINCIPAL DISPLAY PANEL - 30 mL Bottle Carton - Neutral Beige
DERMATOLOGIST DEVELOPED
Exuviance®
CB
CoverBlend
Skin Caring Foundation
with Sunscreen Broad Spectrum
SPF 20
Light to medium, all-day coverage
+
Powerful antiaging benefits
30 mL / 1.0 fl oz
PRINCIPAL DISPLAY PANEL - 30 mL Bottle Carton - Warm Beige
DERMATOLOGIST DEVELOPED
Exuviance®
CB
CoverBlend
Skin Caring Foundation
with Sunscreen Broad Spectrum
SPF 20
Light to medium, all-day coverage
+
Powerful antiaging benefits
30 mL / 1.0 fl oz
PRINCIPAL DISPLAY PANEL - 30 mL Bottle Carton - Honey Sand
DERMATOLOGIST DEVELOPED
Exuviance®
CB
CoverBlend
Skin Caring Foundation
with Sunscreen Broad Spectrum
SPF 20
Light to medium, all-day coverage
+
Powerful antiaging benefits
30 mL / 1.0 fl oz
PRINCIPAL DISPLAY PANEL - 30 mL Bottle Carton - Desert Sand
DERMATOLOGIST DEVELOPED
Exuviance®
CB
CoverBlend
Skin Caring Foundation
with Sunscreen Broad Spectrum
SPF 20
Light to medium, all-day coverage
+
Powerful antiaging benefits
30 mL / 1.0 fl oz
PRINCIPAL DISPLAY PANEL - 30 mL Bottle Carton - Classic Beige
DERMATOLOGIST DEVELOPED
Exuviance®
CB
CoverBlend
Skin Caring Foundation
with Sunscreen Broad Spectrum
SPF 20
Light to medium, all-day coverage
+
Powerful antiaging benefits
30 mL / 1.0 fl oz
PRINCIPAL DISPLAY PANEL - 30 mL Bottle Carton - Golden Beige
DERMATOLOGIST DEVELOPED
Exuviance®
CB
CoverBlend
Skin Caring Foundation
with Sunscreen Broad Spectrum
SPF 20
Light to medium, all-day coverage
+
Powerful antiaging benefits
30 mL / 1.0 fl oz
PRINCIPAL DISPLAY PANEL - 30 mL Bottle Carton - Toasted Almond
DERMATOLOGIST DEVELOPED
Exuviance®
CB
CoverBlend
Skin Caring Foundation
with Sunscreen Broad Spectrum
SPF 20
Light to medium, all-day coverage
+
Powerful antiaging benefits
30 mL / 1.0 fl oz
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| TITANIUM DIOXIDE | ACTIVE INGREDIENT | 15FIX9V2JP | 1 | |
| TITANIUM DIOXIDE | ACTIVE MOIETY | 15FIX9V2JP | 1 | |
| ALUMINUM HYDROXIDE | INACTIVE INGREDIENT | 5QB0T2IUN0 | 1 | |
| AMMONIA | INACTIVE INGREDIENT | 5138Q19F1X | 1 | |
| BUTYLENE GLYCOL | INACTIVE INGREDIENT | 3XUS85K0RA | 1 | |
| CETYL PEG/PPG-10/1 DIMETHICONE (HLB 2) | INACTIVE INGREDIENT | V2W71V8T0X | 1 | |
| CHLORPHENESIN | INACTIVE INGREDIENT | I670DAL4SZ | 1 | |
| CYCLOMETHICONE 5 | INACTIVE INGREDIENT | 0THT5PCI0R | 1 | |
| CYCLOMETHICONE 6 | INACTIVE INGREDIENT | XHK3U310BA | 1 | |
| DISTEARDIMONIUM HECTORITE | INACTIVE INGREDIENT | X687XDK09L | 1 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | 1 | |
| FERRIC OXIDE YELLOW | INACTIVE INGREDIENT | EX438O2MRT | 1 | |
| FERROSOFERRIC OXIDE | INACTIVE INGREDIENT | XM0M87F357 | 1 | |
| GLUCONOLACTONE | INACTIVE INGREDIENT | WQ29KQ9POT | 1 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| HEXYL LAURATE | INACTIVE INGREDIENT | 4CG9F9W01Q | 1 | |
| HIGH DENSITY POLYETHYLENE | INACTIVE INGREDIENT | UG00KM4WR7 | 1 | |
| ISODODECANE | INACTIVE INGREDIENT | A8289P68Y2 | 1 | |
| ISOHEXADECANE | INACTIVE INGREDIENT | 918X1OUF1E | 1 | |
| ISOSTEARYL NEOPENTANOATE | INACTIVE INGREDIENT | 411THY156Q | 1 | |
| LACTOBIONIC ACID | INACTIVE INGREDIENT | 65R938S4DV | 1 | |
| LECITHIN, SOYBEAN | INACTIVE INGREDIENT | 1DI56QDM62 | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | 1 | |
| NYLON-12 | INACTIVE INGREDIENT | 446U8J075B | 1 | |
| PEG-30 DIPOLYHYDROXYSTEARATE | INACTIVE INGREDIENT | 9713Q0S7FO | 1 | |
| PEG/PPG-18/18 DIMETHICONE | INACTIVE INGREDIENT | 9H0AO7T794 | 1 | |
| PERFLUOROOCTYL TRIETHOXYSILANE | INACTIVE INGREDIENT | 814P46684U | 1 | |
| PHENOXYETHANOL | INACTIVE INGREDIENT | HIE492ZZ3T | 1 | |
| POLY(METHYL METHACRYLATE; 450000 MW) | INACTIVE INGREDIENT | Z47NNT4J11 | 1 | |
| POLYGLYCERYL-4 ISOSTEARATE | INACTIVE INGREDIENT | 820DPX33S7 | 1 | |
| POLYMETHYLSILSESQUIOXANE (4.5 MICRONS) | INACTIVE INGREDIENT | 59Z907ZB69 | 1 | |
| PROPYLENE CARBONATE | INACTIVE INGREDIENT | 8D08K3S51E | 1 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 1 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | 1 | |
| SORBITAN SESQUIOLEATE | INACTIVE INGREDIENT | 0W8RRI5W5A | 1 | |
| STEARIC ACID | INACTIVE INGREDIENT | 4ELV7Z65AP | 1 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | 1 | |
| TOCOPHEROL | INACTIVE INGREDIENT | R0ZB2556P8 | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Products#
Every source-derived product name is available through these pages.
- Exuviance CoverBlend Skin Caring Foundation SPF 20 Bisque
- TITANIUM DIOXIDE
- WATER
- CYCLOMETHICONE 6
- CYCLOMETHICONE 5
- ISOSTEARYL NEOPENTANOATE
- TALC
- GLUCONOLACTONE
- ISODODECANE
- BUTYLENE GLYCOL
- ISOHEXADECANE
- NYLON-12
- POLY(METHYL METHACRYLATE; 450000 MW)
- GLYCERIN
- SILICON DIOXIDE
- HIGH DENSITY POLYETHYLENE
- SORBITAN SESQUIOLEATE
- DISTEARDIMONIUM HECTORITE
- PEG-30 DIPOLYHYDROXYSTEARATE (4000 MW)
- SODIUM CHLORIDE
- LACTOBIONIC ACID
- TOCOPHEROL
- LECITHIN, SOYBEAN
- POLYGLYCERYL-4 ISOSTEARATE
- HEXYL LAURATE
- STEARIC ACID
- ALUMINUM HYDROXIDE
- PROPYLENE CARBONATE
- PEG/PPG-18/18 DIMETHICONE
- PERFLUOROOCTYL TRIETHOXYSILANE
- CETYL PEG/PPG-10/1 DIMETHICONE (HLB 2)
- AMMONIA
- MAGNESIUM STEARATE
- POLYMETHYLSILSESQUIOXANE (4.5 MICRONS)
- PHENOXYETHANOL
- CHLORPHENESIN
- FERRIC OXIDE YELLOW
- FERRIC OXIDE RED
- FERROSOFERRIC OXIDE
- Exuviance CoverBlend Skin Caring Foundation SPF 20 Blush Beige
NDC Codes#
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | DROPS / ORAL | NA | ||
| TALC | TALC | 7SEV7J4R1U | TABLET / BUCCAL | 15 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAMUSCULAR | 450 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAVENOUS | 33750 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 60 mg | ||
| AMMONIA | AMMONIA SOLUTION | 5138Q19F1X | SOLUTION / OPHTHALMIC | ADJ PH | ||
| PEG/PPG-18/18 DIMETHICONE | PEG/PPG-18/18 DIMETHICONE | 9H0AO7T794 | GEL / TOPICAL | 1 %w/w | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / RESPIRATORY (INHALATION) | 108 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | LOZENGE / TRANSMUCOSAL | 100 mg | ||
| GLUCONOLACTONE | GLUCONOLACTONE | WQ29KQ9POT | INJECTION / INTRAVENOUS | ADJ PH | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRAVITREAL | 10 %w/v | ||
| TALC | TALC | 7SEV7J4R1U | LOZENGE / ORAL | 50 mg | ||
| TALC | TALC | 7SEV7J4R1U | ELIXIR / ORAL | 4.5 mg/5ml | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 9 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | TABLET / ORAL | 231 mg | ||
| HIGH DENSITY POLYETHYLENE | HIGH DENSITY POLYETHYLENE | UG00KM4WR7 | TABLET, EXTENDED RELEASE / ORAL | 0.64 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TROCHE / ORAL | 315 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE / ORAL | 3487 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE / ORAL | 300 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, DELAYED RELEASE PARTICLES / ORAL | 56 mg | ||
| CYCLOMETHICONE 5 | CYCLOMETHICONE 5 | 0THT5PCI0R | AEROSOL / TOPICAL | 2.5 %w/w | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, ORALLY DISINTEGRATING / ORAL | 68 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION/ DROPS / TOPICAL | 0.86 %w/v | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, EXTENDED RELEASE / ORAL | 173 mg | ||
| FERRIC OXIDE YELLOW | FERRIC OXIDE YELLOW | EX438O2MRT | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, CHEWABLE / ORAL | 127 mg | ||
| HIGH DENSITY POLYETHYLENE | HIGH DENSITY POLYETHYLENE | UG00KM4WR7 | SYSTEM / TRANSDERMAL | NA | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 357 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, DELAYED RELEASE / ORAL | 349 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM, AUGMENTED / TOPICAL | 55 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, SUGAR COATED / ORAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, FILM COATED / ORAL | 1.55 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / BUCCAL | 34 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GUM, CHEWING / BUCCAL | 230 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | SOLUTION / ORAL | 336 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FILM COATED / ORAL | 96 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / TOPICAL | 500 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | GEL / DENTAL | 19 %w/w | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 336 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, FOR SOLUTION / INTRAPLEURAL | 226 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DROPS / ORAL | 300 mg/1ml | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | SOAP / TOPICAL | 6 %w/w | ||
| FERRIC OXIDE YELLOW | FERRIC OXIDE YELLOW | EX438O2MRT | CAPSULE, COATED / ORAL | 0.01 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / SUBARACHNOID | 0.9 %w/v | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | CAPSULE, EXTENDED RELEASE / ORAL | 64 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / PARENTERAL | 584 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, ORALLY DISINTEGRATING / ORAL | 80 mg | ||
| TALC | TALC | 7SEV7J4R1U | GRANULE, DELAYED RELEASE / ORAL | 525 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRATHECAL | 9 mg | ||
| TALC | TALC | 7SEV7J4R1U | SUSPENSION / ORAL | 234 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | SUSPENSION, EXTENDED RELEASE / ORAL | 71 mg | ||
| LECITHIN, SOYBEAN | SOYBEAN LECITHIN | 1DI56QDM62 | POWDER, FOR SUSPENSION / ORAL | 39 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / SUBCUTANEOUS | 0.8 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | AEROSOL, FOAM / TOPICAL | 21 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SPRAY, METERED / NASAL | 36 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRATUMOR | 1.2 %w/v | ||
| ALUMINUM HYDROXIDE | ALUMINUM HYDROXIDE | 5QB0T2IUN0 | OINTMENT / TOPICAL | NA | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SYSTEM / TOPICAL | 3.1 mg | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | AEROSOL, FOAM / TOPICAL | 72 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | LIQUID / NASAL | 7.4 mg/1ml |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 1647fc51-868c-4b58-8345-c864593d7b57 | 67fc1b45-a7fb-4d6d-a1c2-aa209ef8808d | 2020-01-24 | Warnings | 1647fc51-868c-4b58-8345-c864593d7b57 67fc1b45-a7fb-4d6d-a1c2-aa209ef8808d |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.